Brief: Ascentage Pharma Group International Posts HY Loss Attributable RMB 319.2 MLN
18/08/2020 14:05
Aug 18 (Reuters) - Ascentage Pharma Group International
6855.HK :
* HY LOSS ATTRIBUTABLE RMB 319.2 MILLION VERSUS LOSS OF RMB
633.3
MILLION
Source text for Eikon: ID:nHKS7vnXC4
Further company coverage: 6855.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascentage Pharma International
See all newsBrief: Ascentage Pharma Group Says Lisaftoclax Granted Breakthrough Therapy Designation In China
China's Ascentage Pharma climbs as chairman buys shares on market
Brief: Ascentage Pharma Group International's Chairman Buys 38,630 Shares
Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-up